tailieunhanh - Intrathecal baclofen treatment in dystonic cerebral palsy: A randomized clinical trial: The IDYS trial

Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. | Intrathecal baclofen treatment in dystonic cerebral palsy: A randomized clinical trial: The IDYS trial

TỪ KHÓA LIÊN QUAN